Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels

被引:79
作者
Akyuz, Umit [1 ,2 ]
Yesil, Atakan [1 ]
Yilmaz, Yusuf [3 ,4 ]
机构
[1] Yeditepe Univ, Fac Med, Dept Gastroenterol, Istanbul, Turkey
[2] Fatih Sultan Mehmet Educ & Res Hosp, Dept Gastroenterol, Istanbul, Turkey
[3] Marmara Univ, Inst Gastroenterol, TR-34840 Istanbul, Turkey
[4] Marmara Univ, Dept Gastroenterol, Sch Med, TR-34840 Istanbul, Turkey
关键词
body mass index; fibrosis; hemoglobin; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; NAFLD; PREVALENCE; PHLEBOTOMY; DIAGNOSIS;
D O I
10.3109/00365521.2014.983160
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Overweight and obesity are major risk factors for the development of nonalcoholic fatty liver disease (NAFLD). However, a minority of NAFLD patients have a body mass index (BMI) < 25 kg/m(2) (lean NAFLD). We sought to investigate whether significant differences exist between lean NAFLD and more common forms of NAFLD associated with overweight/obesity. Patients and methods. A total of 483 consecutive patients with biopsy-proven NAFLD were enrolled. Lean NAFLD was defined as having a BMI < 25 kg/m(2). We identified 37 patients with lean NAFLD (7.6%). Results. Compared with NAFLD patients with overweight/obesity, lean NAFLD patients were younger, had lower blood pressure values, higher levels of hemoglobin, a lower prevalence of the metabolic syndrome, and less severe hepatic fibrosis. In NAFLD patients with overweight/obesity, diabetes was the only independent predictor of nonalcoholic steatohepatitis (NASH). In lean NAFLD, the only variable independently associated with NASH was hemoglobin. Alanine aminotransferase and diabetes were independent predictors of fibrosis >= 2 in NAFLD patients with overweight/obesity, whereas hemoglobin was the only independent predictor of fibrosis >= 2 in lean NAFLD. Conclusion. In summary, lean NAFLD patients are younger and show less severe hepatic fibrosis. However, such subjects have higher hemoglobin levels, which seem to predict the histological severity.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 28 条
[1]  
Bai CH, 2014, CHIN J PHYSL, V57, P5
[2]   Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease [J].
Beaton, M. D. ;
Chakrabarti, S. ;
Levstik, M. ;
Speechley, M. ;
Marotta, P. ;
Adams, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) :720-729
[3]   Pathology of nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (04) :195-203
[4]   Review of Treatment Options for Nonalcoholic Fatty Liver Disease [J].
Corrado, Richele L. ;
Torres, Dawn M. ;
Harrison, Stephen A. .
MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) :55-+
[5]  
Dela Cruz AC, 2014, CHARACTERISTICS LONG
[6]   Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging [J].
Dyson, Jessica K. ;
Anstee, Quentin M. ;
McPherson, Stuart .
FRONTLINE GASTROENTEROLOGY, 2014, 5 (03) :211-218
[7]   Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications [J].
Fabbrini, Elisa ;
Sullivan, Shelby ;
Klein, Samuel .
HEPATOLOGY, 2010, 51 (02) :679-689
[8]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239
[9]   Serum Iron Concentration, but Not Hemoglobin, Correlates with TIMI Risk Score and 6-Month Left Ventricular Performance after Primary Angioplasty for Acute Myocardial Infarction [J].
Huang, Ching-Hui ;
Chang, Chia-Chu ;
Kuo, Chen-Ling ;
Huang, Ching-Shan ;
Chiu, Tzai-Wen ;
Lin, Chih-Sheng ;
Liu, Chin-San .
PLOS ONE, 2014, 9 (08)
[10]   Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver [J].
Jiang, Youzhao ;
Zeng, Jun ;
Chen, Bing .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) :1508-1514